Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy (Q43626109)

25 November 2017

title

Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy (English)

1 reference

25 November 2017

0 references

Yuji Nagatomo

1

1 reference

25 November 2017

Akiyasu Baba

2

1 reference

25 November 2017

Hiroyuki Ito

3

1 reference

25 November 2017

Kotaro Naito

4

1 reference

25 November 2017

Akihiro Yoshizawa

5

1 reference

25 November 2017

Yasuo Kurita

6

1 reference

25 November 2017

Iwao Nakamura

7

1 reference

25 November 2017

Toshiaki Monkawa

8

1 reference

25 November 2017

Takashi Matsubara

9

1 reference

25 November 2017

Yasuhisa Wakabayashi

10

1 reference

25 November 2017

Satoshi Ogawa

11

1 reference

25 November 2017

Makoto Akaishi

12

1 reference

25 November 2017

Tsutomu Yoshikawa

13

1 reference

25 November 2017

publication date

27 October 2010

1 reference

Journal of Clinical Apheresis

25 November 2017

published in

1 reference

25 November 2017

volume

26

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

1-8

1 reference

Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo

25 November 2017

cites work

1 reference

Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes

21 January 2018

1 reference

Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

21 January 2018

1 reference

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

21 January 2018

1 reference

Immunoadsorption therapy for myasthenia gravis

21 January 2018

1 reference

21 January 2018

1 reference

Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy

21 January 2018

1 reference

Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

Beta 1-adrenoceptor autoimmunity in cardiomyopathy

21 January 2018

1 reference

Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.

21 January 2018

1 reference

A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure.

21 January 2018

1 reference

Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy

21 January 2018

1 reference

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption

21 January 2018

1 reference

Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro study

21 January 2018

1 reference

Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: Immunoglobulin G3 and clinical correlates

21 January 2018

1 reference

Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCA.20268

1 reference

25 November 2017

1 reference